|
WO2020189799A1
|
|
Method for culturing hepatic epithelioid tissue having a structure of connections between hepatocytes and cholangiocytes
|
|
WO2020184729A1
|
|
Pharmaceutical composition for treating amyotrophic lateral sclerosis
|
|
WO2020162580A1
|
|
Pharmaceutical composition for preventing in-stent restenosis
|
|
WO2020071554A1
|
|
Cancer-stem-cell-specific antibody
|
|
KR20210028659A
|
|
Observation device
|
|
CN112004922A
|
|
Cell sheet for biological transplantation and method for producing same
|
|
JP2020180871A
|
|
Method of acquiring information on pathology of interstitial pneumonia patient, and use thereof
|
|
WO2019189772A1
|
|
Cancer-treating agent that targets at long-chain non-coding rna, and cancer diagnosis method
|
|
WO2019189596A1
|
|
Biological information measurement device
|
|
JP2020143037A
|
|
Therapeutic pharmaceutical composition for heart failure associated with diabetes
|
|
JP2019137681A
|
|
Composition for promoting mesenchymal stem cell growth and composition for improving cognitive function
|
|
KR20200085818A
|
|
Medicine for tissue regeneration and its manufacturing method
|
|
JP2020019749A
|
|
Therapeutic agent for controlling cancer microenvironment
|
|
JP2020007260A
|
|
Cancer therapeutic agent targeting a long non-coding rna and methods for predicting cancer diagnosis and prognosis
|
|
WO2018199194A1
|
|
Method for producing mesenchymal stem cells, therapeutic effect marker of mesenchymal stem cells, method for determining therapeutic effects of mesenchymal stem cells, and cellular preparation containing mesenchymal stem cells
|
|
US2020113455A1
|
|
Baroreflex vascular sympathetic nervous activity detection device, baroreflex vascular sympathetic nervous activity detection program, and baroreflex vascular sympathetic nervous activity detection method
|
|
JP2019071853A
|
|
Methods for screening antimicrobial agents
|
|
WO2018034314A1
|
|
Mesenchymal stem cell activation agent
|
|
WO2018021553A1
|
|
Isolator
|
|
WO2017195794A1
|
|
Cell observation apparatus and program
|
